The evidence for Cannabidiol is building

By Danélia Botes

March 27, 2023

Cannabidiol has been licensed as an add-on treatment for seizures caused by tuberous sclerosis complex for patients aged 2 years and over. Clinical trial evidence shows that it reduces seizure frequency and increases seizure-free days compared to ...

When you collaborate with VSH Foundation, it's like unlocking a new dimension in healthcare innovation.

Our research synergizes with your vision, combining expertise in health economics, policy analysis, advanced analytics, and AI applications in healthcare. You’ll witness the fusion of cutting-edge methodologies and real- world impact, as we work together to transform healthcare systems and improve patient outcomes globally.

CORRESPONDENCE ADDRESS

PO Box 8547, #95478, Boston, MA 02114, USA

© 2024 Value Science Health Foundation. All rights reserved.
Made with by Frogiez